Fulcrum Therapeutics, Inc. (FULC) income statement
FULCNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.69−0.02 (-0.54%)
Close on Nov 20, 2026Market cap $281.54MP/E –Yield –
Fulcrum Therapeutics, Inc. financial ratios
See a number that looks wrong?